Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma

PHASE3CompletedINTERVENTIONAL
Enrollment

311

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Adenocarcinoma, Prostate
Interventions
DRUG

Cyproterone acetate

Cyproterone acetate tablet-in-capsule.

DRUG

Medroxyprogesterone acetate

Medroxyprogesterone acetate tablet-in-capsule.

DRUG

Venlafaxine

Venlafaxine capsule.

DRUG

Leuprorelin

Leuprorelin injection.

DRUG

Flutamide

Flutamide tablet

DRUG

Placebo

Cyproterone acetate, medroxyprogesterone acetate or venlafaxine placebo-matching capsule.

Trial Locations (1)

86021

Professor Jacques IRANI, Poitiers

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY